Similar User
@ronanhsieh
@BlessieNelson
@c_vakka
@AkritiGJain
@ChenyuLinMD
@KarapetLilit
@LuisMezaco
@BenMironMD
@ArushiSinghMD
@Triplet_Trav
@abavishi23
@jblanter
Significant OS benefit of pembro. Now questions are: do we need that much chemo; do we need adj pembro after pCR; is there signature of response; what do we do with T1c? Great discussion below. @SABCSSanAntonio @stolaney1 @KateIdaLathrop #sabcssnippets
.@stolaney1 and #SABCS24 program director @KateIdaLathrop discussed the phase III KEYNOTE-522 trial, which recently met its overall survival endpoints in patients with high-risk early-stage TNBC. Watch now on #SABCSSnippets: bit.ly/3R4pRHB @UTHealthSAMDA
A wonderful collaborative effort with 4 institutions @LubnaChaudhary1 @YAbdouMD @SabaShaikhMD @royaryam Real world outcome data with sacituzumab govitecan in metastatic breast cancer.
Great to have multi institution collaboration with clinically driven hem onc fellows @DrNH590 @royaryam @MCWCancerCenter @Froedtert @RoswellPark P03-06-10: Real world outcomes with Saci in mTNBC. @gandhi_shipra #breastcancer #clinicaltrials #sabcs23
In the middle of a discombobulated week, a multiple bad scans-kind of a day, a running 2 hours behind day, there’s a person that just wants to tell you how grateful they are to be alive, for the team’s care of them over the years. Suddenly time stops. And that’s oncology folks 🙏
We can finally complete the table with all results (PFS and OS) from the CDK4/6 inhibitors phase III trials in HR+/HER2- MBC 👇🏽 OS in Paloma-2 was the only outcome did not meet significant difference 🪄🤨
An important study by @EMittendorfMD Of those with clinical node- TNBC ~10% of T1ab tumors, + ~15% of T1c tumors will be node + at surgery. Important implications for who needs preop tx + pembro. Consider axillary US in these pts @OncoAlert pubmed.ncbi.nlm.nih.gov/35941343/
Group photo of the home crew from Fox Chase 📸@FoxChaseCancer @TempleHealth at #vailworkshop #MCCR22 @ASCO @AACR with @BenMironMD @JJuddOnc Saba Shaikh and Cyrus Mazidi - snapped at a rare moment when we were not hard at work on protocols! Photo credit @ronanhsieh
Congratulations to our amazing @PittHemeOnc class of 2022! So incredibly proud of all of you @KarapetLilit @MaxJLee @SabaShaikhMD @UPMCHillmanCC
United States Trends
- 1. Bengals 74,8 B posts
- 2. Chargers 62,5 B posts
- 3. McPherson 11,2 B posts
- 4. Herbert 32,7 B posts
- 5. Joe Burrow 18,9 B posts
- 6. #BoltUp 5.144 posts
- 7. Zac Taylor 4.020 posts
- 8. #CINvsLAC 9.986 posts
- 9. #BaddiesMidwest 18,3 B posts
- 10. #SNFonNBC N/A
- 11. JK Dobbins 4.169 posts
- 12. Money Mac N/A
- 13. Harbaugh 15,1 B posts
- 14. Ladd 5.336 posts
- 15. #WhoDey 1.747 posts
- 16. Chiefs 155 B posts
- 17. Tee Higgins 3.643 posts
- 18. WWIII 156 B posts
- 19. Russia 753 B posts
- 20. Josh Allen 67,5 B posts
Who to follow
-
Ronan Hsieh, MD, MS
@ronanhsieh -
Blessie Elizabeth Nelson MBBS, DMRT
@BlessieNelson -
Chetan Vakkalagadda, MD
@c_vakka -
Akriti Jain
@AkritiGJain -
Chenyu Lin, MD
@ChenyuLinMD -
Lilit Karapetyan
@KarapetLilit -
Luis A. Meza
@LuisMezaco -
Ben Miron
@BenMironMD -
Arushi Singh
@ArushiSinghMD -
Travis Howard
@Triplet_Trav -
Aakash Bavishi
@abavishi23 -
Julia Blanter, MD
@jblanter
Something went wrong.
Something went wrong.